Effect of lovastatin on cerebral circulation in spontaneously hypertensive rats

Hypertension

Volumn 35, Issue 5, 2000, Pages 1105-1110

  Régrigny, Olivier ^a   Atkinson, Jeffrey ^a   Capdeville Atkinson, Christine ^a   Limiñana, Patrick ^a   Chillon, Jean Marc ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Autoregulation; Hypertrophy; Inhibitors, HMG CoA reductase; Remodeling

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN;

ADOLESCENT; ANIMAL MODEL; ARTERIOLE; ARTERY COMPLIANCE; ARTERY DIAMETER; ARTICLE; AUTOREGULATION; BRAIN BLOOD FLOW; BRAIN CIRCULATION; CONTROLLED STUDY; DRUG EFFECT; HYPERTENSION; HYPERTROPHY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STRESS STRAIN RELATIONSHIP; VASCULAR DISEASE;

EID: 0343527282     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.35.5.1105     Document Type: Article

References (34)

1. Blauw GJ, Lagaay AM, Smelt AHM, Westendorp RGJ. Stroke, statins, and cholesterol: a meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors. Stroke. 1997;28: 946-950.
2. Crouse JR, Byington RP, Furberg CD. HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data. Atherosclerosis. 1998;138:11-24.
3. Jiang J, Roman RJ. Lovastatin prevents development of hypertension in spontaneously hypertensive rats. Hypertension. 1997;30:968-974.
4. Kita T, Brown MS, Goldstein JL. Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase. J Clin Invest. 1980; 66:1094-1100.
5. Harper SL, Bohlen HG. Microvascular adaptation in the cerebral cortex of adult spontaneously hypertensive rats. Hypertension. 1984;6:408-419.
6. Chillon JM, Heistad DD, Baumbach GL. Effects of endothelin receptor inhibition on cerebral arterioles in hypertensive rats. Hypertension. 1996; 27:794-798.
7. Chillon JM, Ghoneim S, Baumbach GL. Effects of chronic nitric oxide synthase inhibition on cerebral arterioles in rats. Hypertension. 1997;30: 1097-1104.
8. Fuji K, Heistad DD, Faraci FM. Role of the basilar artery in the regulation of blood flow to the brain stem in the rats. Stroke. 1991;22:763-767.
9. Baumbach GL, Walmsley JG, Hart MN. Composition and mechanics of cerebral arterioles in hypertensive rats. Am J Pathol. 1988;133:464-471.
10. Barry DI, Strandgaard S, Graham DI, Braendstrup O, Svendsen UG, Vorstrup S, Hemmingsen R, Bolwig TG. Cerebral blood flow in rats with renal and spontaneous hypertension: resetting of the lower limit of autoregulation. J Cereb Blood Flow Metab. 1982;2:347-353.
11. Lartaud I, Bray-des-Boscs L, Chillon JM, Atkinson J, Capdeville-Atkinson C. In vivo cerebrovascular reactivity in Wistar and Fischer 344 rat strains during aging. Am J Physiol. 1993;264(Heart Circ Physiol 26):H851-H858.
12. Baumbach GL, Heistad DD. Adaptive changes in cerebral blood vessels during chronic hypertension. J Hypertens. 1991;9:987-991.
13. Kontos HA, Wei EP, Navari RM, Levasseur JE, Rosenblum WI, Patterson JLJ. Responses of cerebral arteries and arterioles to acute hypotension and hypertension. Am J Physiol. 1978;234:371-383.
14. Stromberg DD, Fox J. Pressures in the pial arterial microcirculation of the cat during changes in systemic arterial blood pressure. Circ Res. 1972; 31:229-239.
15. Chillon JM, Baumbach GL. Functional and structural alterations of cerebral arterioles in chronic hypertension induced by nitric oxide synthesis inhibition. Br J Pharmacol. 1995;114:127P. Abstract.
16. Baumbach GL, Heistad DD. Mechanics of cerebral arterioles in chronic hypertension. In: Halpern W, Pegram BL, Brayden J, MacKay K, McLaughlin M, Osol G, eds. Second International Symposium on Resistance Arteries. Ithaca, NY: Perinatology Press,; 1988;355-361.
17. Dobrin PB, Rovick AA. Influence of vascular smooth muscle on contractile mechanics and elasticity of arteries. Am J Physiol. 1969;217: 1644-1651.
18. Baumbach GL, Siems JE, Heistad DD. Effects of local reduction in pressure on distensibility and composition of cerebral arterioles. Circ Res. 1991;68:338-351.
19. Jones JV, Fitch W, McKenzie ET, Strandgaard S, Harper AM. Lower limit of cerebral blood flow autoregulation in experimental renovascular hypertension in the baboon. Circ Res. 1976;39:555-557.
20. Barry DI, Lassen NA. Cerebral blood autoregulation in hypertension and effects of hypertensive drugs. J Hypertens. 1984;2:S519-S526.
21. Barry DI. Cerebral blood flow in hypertension. J Cardiovasc Pharmacol. 1985;7:S94-S98.
22. Folkow B, Grimby G, Thulesius O. Adaptive structural changes of the vascular walls in hypertension and their relation to the control of the peripheral resistance. Acta Physiol Scand. 1958;44:255-272.
23. Folkow B. The fourth Volhard lecture: cardiovascular structural adaptation: its role in the initiation and maintenance of primary hypertension. Clin Sci Mol Med Suppl. 1978;4:3s-22s.
24. Folkow B, Hallbäck M, Lundgren Y, Sivertsson R, Weiss L. Importance of adaptive changes in vascular design for establishment of primary hypertension, studied in man and in spontaneously hypertensive rats. Circ Res. 1973;32:I-2-I-16.
25. Baumbach GL, Heistad DD. Remodeling of cerebral arterioles in chronic hypertension. Hypertension. 1989;13:968-972.
26. Paulson OB, Strandgaard S. Antihypertensive treatment and the cerebral circulation. J Cardiovasc Pharmacol. 1987;10:5104-8107.
27. Baumbach GL. Effects of increased pulse pressure on cerebral arterioles. Hypertension. 1996;27:159-167.
28. Lartaud I, Makki T, Bray-des-Boscs L, Niederhoffer N, Atkinson J, Corman B, Capdeville-Atkinson C. Effect of chronic ANG I-converting enzyme inhibition on aging processes, IV: cerebral blood flow autoregulation. Am J Physiol. 1994;267:R687-R694.
29. Hughes AD. The role of isoprenoids in vascular smooth muscle: potential benefits of statins unrelated to cholesterol lowering. J Hum Hypertens. 1996;10:387-390.
30. Nègre-Aminou P, van Vliet AK, van Erck M, van Thiel GCF, van Leeuwen REW, Cohen LH. Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types. Biochim Biophys Acta. 1997; 1345:259-268.
31. Munro E, Patel M, Chan P, Betteridge L, Clunn G, Gallagher K, Hughes A, Schachter M, Wolfe J, Sever P. Inhibition of human vascular smooth muscle cell proliferation by lovastatin: the role of isoprenoid intermediates of cholesterol synthesis. Eur J Clin Invest. 1994;24:766-772.
32. Endres M, Laufs U, Huang Z, Nakamura T, Huang P, Moskowitz MA, Liao JK. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA. 1998;95:8880-8885.
33. Baumbach GL, Hadju MA. Mechanics and composition of cerebral arterioles in renal and spontaneously hypertensive rats. Hypertension. 1993; 21:816-826.
34. Baumbach GL, Heistad DD, Siems JE. Effect of sympathetic nerves on composition and distensibility of cerebral arterioles in rats. J Physiol. 1989;416:123-140.